In May 2023, the FDA has unveiled its definitive guidance titled “Adjusting for Covariates in Randomized Clinical Trials (RCT) for Drugs…
Patient adherence remains a significant challenge in clinical research and medical practice, affecting drug development, healthcare costs, and…
We are proud to be a finalist for the award of ‘Scale-up de l’Année – Scale-up of the…
We are pleased to share that our very own Dominique Demolle, CEO, has been recognized as one of…
Drug development has changed significantly throughout the past 2 decades – including great leaps forward in areas from…
New research suggests that a high percentage of reported side effects from COVID-19 vaccines may be due to what’s…